Guggenheim Securities Initiates Sucampo Pharmaceuticals With Buy By: Benzinga via Benzinga April 06, 2015 at 09:37 AM EDT Analysts at Guggenheim Securities initiated coverage on Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) with a Buy rating. The target ... Read More >>